Buy Enclomimed 25 (Enclomiphene Citrate) | DEUSPOWER

ENCLOMIMED 25 (Enclomiphene Citrate) - SERM Tablets

PRODUCT OVERVIEW

ENCLOMIMED 25 (Enclomiphene Citrate) by Deus Medical is an oral SERM tablet used in post‑cycle phases that require well-defined and predictable doses. This tablet format removes the need for trial and error as it provides consistent strength of 25 mg per tablet, and transparent labelling for those who require precision in their programme. These important factors allow users who buy enclomiphene in the EU to introduce it when a cycle is concluded; for when they want their hormone function to return to baseline in a structured way.

KEY FEATURES

• Active Ingredient: Enclomiphene Citrate
• Classification: Selective Oestrogen Receptor Modulator (SERM)
• Form: Film-coated oral tablets
• Strength: 25 mg per tablet
• Brand: Deus Medical
• Package Content: 1 box of 2 × 25 tablets (50 tablets total)
• Also Known As: Enclomiphene, Enclomi

BENEFITS

• Post‑cycle structure: Commonly used in PCT plans with the primary goal of supporting a return to normal hormone activity and function after a cycle.
• Straightforward dosing: Fixed 25 mg strength per tablet simplifies the dosing ladder and avoids complicated splitting or measuring.
• SERM Choice: Selected by users who prefer a selective oestrogen receptor modulator for PCT instead of broader‑acting options.
• Flexible planning: Can be slotted into shorter or longer post‑cycle layouts; all dependent upon cycle length, stacked compounds, and individual response.

USAGE INSTRUCTIONS

• Dosage: ENCLOMIMED 25 (Enclomiphene Citrate) comes in 25 mg tablets. A common approach is to start with a lower intake, such as a partial 12.5 mg dose, and move toward the full 25 mg tablet as needed. Conservative starts are generally preferred over aggressive initial doses.
• Timing: Enclomimed 25 is usually taken once daily at the same time each day to maintain consistent levels. Most users choose either a morning or early-evening schedule and keep it fixed throughout the post-cycle period.
• Consistency: Post-cycle plans require stable dosing to be effective. It is recommended to decide on a clear dosing ladder at the start. For example, a lower dose in week one followed by a step up. It is imperative to follow it without frequent or random changes.
• Protocol: This compound is generally used as part of a wider PCT framework and can be combined with other support products. Typical runs last several weeks, with the exact length determined by the compounds used in the preceding cycle and individual recovery goals.

IMPORTANT INFORMATION

• Consult a professional: Health guidance is strongly advised before starting ENCLOMIMED 25, especially for those with a history of hormone‑related conditions, liver issues, or other underlying health concerns.
• Not recommended: Strictly not for pregnant or breastfeeding women, or for individuals under 18 years of age.
• Dosage caution: Do not exceed the daily intake outlined in your plan or suggested by a qualified professional.
• Duration: Do not extend post‑cycle use beyond the intended PCT window without reassessing the overall plan and health markers.

STORAGE

• Store below 30°C.
• Protect from light.
• Do not freeze.
• Keep out of reach of children.

LEGAL DISCLAIMER

This product is intended for use only in accordance with applicable laws and regulations. The information provided is for educational purposes and does not replace medical advice. Misuse may involve health risks. Seek professional guidance where appropriate.

WHY CHOOSE OUR ENCLOMIMED 25 (ENCLOMIPHENE CITRATE)?

• Defined tablet strength: Each Enclomimed 25 tablet carries exactly 25 mg of enclomiphene citrate as indicated on both sides of the box and blister packs. This guides you through a specific post-cycle plan minus the guesswork on dosing.
• Post-cycle focus: Enclomimed 25 is intended for use in PCT layouts rather than during an active cycle. Having a compound dedicated to this phase makes organising a recovery plan easier with its clear and defined purpose.
• Practical oral format: These tablets do not require any special preparation or refrigeration. For those who have finished a cycle involving multiple injectables, a simple oral option can be a more straightforward way to manage the post-cycle period.
• Brand Consistency: Deus Medical maintains the same standards for labelling and batch documentation across its entire range. If you use multiple products from this brand, this consistency makes it easier to keep accurate logs and track your progress over time.

FAQ